(STOK) Stoke Therapeutics - Performance -19% in 12m
Compare STOK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-71.70%
#98 in Group
Rel. Strength
28.15%
#5717 in Universe
Total Return 12m
-18.96%
#62 in Group
Total Return 5y
-60.36%
#64 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -27.64%
(?) Percentile in Group
12m Total Return: STOK (-19%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: STOK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for STOK
Total Return (including Dividends) | STOK | XBI | S&P 500 |
---|---|---|---|
1 Month | 33.33% | 2.77% | 5.69% |
3 Months | -9.30% | -14.21% | -6.49% |
12 Months | -18.96% | -14.88% | 9.72% |
5 Years | -60.36% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | STOK | XBI | S&P 500 |
1 Month | 57.1% | 57% | 89.4% |
3 Months | -4.70% | -82.3% | -72% |
12 Months | -87.0% | -53.1% | 49.3% |
5 Years | -77.6% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #9 | 29.7% | 26.2% |
3 Month | #95 | 5.72% | -3.01% |
12 Month | #63 | -4.79% | -26.1% |
5 Years | #64 | -46.1% | -80.9% |
FAQs
Does STOK Stoke Therapeutics outperforms the market?
No,
over the last 12 months STOK made -18.96%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months STOK made -9.30%, while XBI made -14.21%.
Over the last 3 months STOK made -9.30%, while XBI made -14.21%.
Performance Comparison STOK vs Indeces and Sectors
STOK vs. Indices STOK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.66% | 27.6% | -27.1% | -28.7% |
US NASDAQ 100 | QQQ | -3.93% | 25.9% | -27.5% | -29.8% |
US Dow Jones Industrial 30 | DIA | -3.55% | 30.7% | -26.0% | -25.2% |
German DAX 40 | DAX | -4.11% | 18.3% | -52.7% | -43.8% |
Shanghai Shenzhen CSI 300 | CSI 300 | -3.89% | 30.5% | -26.3% | -25.3% |
Hongkong Hang Seng | HSI | -6.54% | 18.4% | -36.6% | -27.2% |
India NIFTY 50 | INDA | 0.04% | 30.1% | -29.0% | -21.0% |
Brasil Bovespa | EWZ | -6.69% | 21.7% | -36.3% | -12.7% |
STOK vs. Sectors STOK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.03% | 26.9% | -33.3% | -39.3% |
Consumer Discretionary | XLY | -5.08% | 26.6% | -24.9% | -33.8% |
Consumer Staples | XLP | -2.80% | 32.6% | -34.0% | -26.2% |
Energy | XLE | -5.91% | 28.8% | -21.1% | -9.94% |
Financial | XLF | -4.36% | 26.5% | -33.0% | -40.5% |
Health Care | XLV | 0.44% | 36.4% | -21.8% | -13.0% |
Industrial | XLI | -4.59% | 25.0% | -28.1% | -29.3% |
Materials | XLB | -3.82% | 28.3% | -23.0% | -12.9% |
Real Estate | XLRE | -2.87% | 26.4% | -29.5% | -32.5% |
Technology | XLK | -4.50% | 23.6% | -24.8% | -25.1% |
Utilities | XLU | -4.38% | 28.2% | -34.8% | -35.0% |
Aerospace & Defense | XAR | -3.84% | 24.2% | -36.4% | -44.9% |
Biotech | XBI | 4.06% | 30.6% | -6.01% | -4.08% |
Homebuilder | XHB | -3.30% | 27.7% | -13.4% | -10.1% |
Retail | XRT | -3.72% | 27.2% | -20.8% | -12.7% |